Vitalibis, Inc.
VCBDQ · OTC
12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | |
|---|---|---|---|---|
| Revenue | $303 | $51 | $0 | $0 |
| % Growth | 490.7% | – | – | – |
| Cost of Goods Sold | $163 | $23 | $0 | $0 |
| Gross Profit | $141 | $28 | $0 | $0 |
| % Margin | 46.4% | 55.2% | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $6,024 | $2,256 | $0 | $0 |
| SG&A Expenses | $6,024 | $2,256 | $103 | $61 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | -$0 | $0 |
| Operating Expenses | $6,024 | $2,256 | $103 | $61 |
| Operating Income | -$5,883 | -$2,228 | -$103 | $61 |
| % Margin | -1,940.5% | -4,340.3% | – | – |
| Other Income/Exp. Net | -$963 | -$1 | -$0 | -$122 |
| Pre-Tax Income | -$6,846 | -$2,229 | -$103 | -$61 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$6,846 | -$2,229 | -$103 | -$61 |
| % Margin | -2,257.9% | -4,341.7% | – | – |
| EPS | -0.22 | -0.078 | -0.004 | -0.003 |
| % Growth | -182.8% | -1,752.4% | -55.6% | – |
| EPS Diluted | -0.22 | -0.078 | -0.004 | -0.003 |
| Weighted Avg Shares Out | 30,958 | 28,644 | 24,398 | 22,635 |
| Weighted Avg Shares Out Dil | 30,958 | 28,644 | 24,398 | 22,635 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1,054 | $1 | $0 | $0 |
| Depreciation & Amortization | $59 | $27 | $53 | -$122 |
| EBITDA | -$4,679 | -$2,201 | -$103 | -$61 |
| % Margin | -1,543.2% | -4,287.6% | – | – |